[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:histiocytic-and-dendritic-cell-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Histiocytic and Dendritic Cell Neoplasm",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06153173","Mirdametinib in Histiocytic Disorders",[11],"Phase 2","RECRUITING","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:27.518916Z"]